StonvexLoading…
StonvexStonvexStonvexCore line items from CURI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $15.16M | $71.66M | $52.46M | $34.10M |
Operating Income | $-1.54M | $-7.30M | $-3.93M | $559.00K |
Net Income | $-1.33M | $-6.43M | $-2.64M | $784.00K |
EPS (Diluted) | $-0.02 | $-0.11 | $-0.05 | $0.02 |
Total Assets | $69.16M | $75.73M | $74.70M | $78.65M |
Total Liabilities | $32.70M | $34.24M | $27.51M | $28.81M |
Cash & Equivalents | $16.90M | $18.32M | $14.11M | $6.94M |
Free Cash Flow OCF − CapEx | $1.21M | $12.96M | $9.01M | $4.63M |
Shares Outstanding | 59.29M | 58.73M | 58.08M | 57.71M |